Abbott Laboratories ABT
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
What this company does
Written from the business description in ABBOTT LABORATORIES's annual report to the U.S. Securities and Exchange Commission, filed 20 February 2026. Every sentence was checked against that document before publication.
Growth
Revenue compounded at +5.1% a year over the five years to FY2025 — but profit grew faster: net income at +7.7%, earnings per share at +8.3%.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
Each USD of equity produced 13 cents of profit this year.
The 19-year record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 44.3 | 42.0 | 40.1 | 43.7 | 43.1 | 34.6 | 31.9 | 30.6 | 27.4 | 20.9 | 20.4 | 20.2 | 19.7 | 19.1 | 21.4 | 35.2 | 30.8 | 29.5 | 25.9 |
| Operating income $B | 8.1 | 6.8 | 6.5 | 8.4 | 8.4 | 5.4 | 4.5 | 3.6 | 1.6 | 3.0 | 2.9 | 2.6 | 2.1 | 1.4 | 1.6 | 6.1 | 6.2 | 5.7 | 4.6 |
| EBITDA $B | 9.5 | 8.2 | 7.8 | 9.6 | 9.9 | 6.6 | 5.6 | 4.8 | 2.6 | 3.8 | 3.7 | 3.5 | 3.1 | 2.7 | 3.0 | 7.3 | 7.4 | 6.7 | 5.7 |
| Income tax $B | 1.9 | −6.4 | 0.9 | 1.4 | 1.1 | 0.5 | 0.4 | 0.5 | 1.9 | 0.3 | 0.6 | 0.8 | 0.1 | −0.5 | 0.1 | 1.1 | 1.4 | 1.1 | 0.9 |
| Net income $B | 6.5 | 13.4 | 5.7 | 6.9 | 7.1 | 4.5 | 3.7 | 2.4 | 0.5 | 1.4 | 4.4 | 2.3 | 2.6 | 6.0 | 4.7 | 4.6 | 5.7 | 4.9 | 3.6 |
| Free cash flow $B | 7.4 | 6.4 | 5.1 | 7.8 | 8.6 | 5.7 | 4.5 | 4.9 | 4.4 | 2.1 | 1.9 | 2.6 | 2.2 | 7.5 | 7.5 | 7.7 | 6.2 | 5.7 | 3.5 |
| EPS, diluted $ | 3.72 | 7.64 | 3.26 | 3.91 | 3.94 | 2.50 | 2.06 | 1.33 | 0.27 | 0.94 | 2.92 | 1.49 | 1.62 | 3.72 | 3.01 | 2.96 | 3.69 | 3.12 | 2.31 |
| Dividend / sh $ | 2.40 | 2.24 | 2.08 | 1.92 | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ | 1.92 | 1.76 | 1.60 | ◌ | ◌ |
| Payout % | 63 | 29 | 62 | 48 | 45 | 57 | 62 | 83 | 388 | 110 | 33 | 59 | 34 | 53 | 62 | 58 | 42 | 45 | 54 |
| ROE % | 13.1 | 31.1 | 15.2 | 19.1 | 20.6 | 14.1 | 12.0 | 7.7 | 1.9 | 6.7 | 20.7 | 9.8 | 9.9 | 23.3 | 20.1 | 20.2 | 28.3 | 27.7 | 20.3 |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 19 of the 19 fiscal years we could check.